19 June 2013
Keywords: immunex, drops, plans, develop, enbrel, crohn, disease
Article | 14 February 2001
Immunex has decided not to press ahead with the development of itsanti-tumor necrosis factor drug Enbrel (etanercept) as a treatment ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
14 February 2001
15 February 2001
© 2013 thepharmaletter.com